These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22834939)

  • 1. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.
    Shapiro EY; Lipsky MJ; Cha DY; McKiernan JM; Benson MC; Gupta M
    J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel treatment of upper tract urothelial carcinoma in situ with docetaxel in BCG refractory patients.
    Katims AB; Tam AW; Rosen DC; Zampini AM; Atallah W; Mehrazin R; Gupta M
    Urol Oncol; 2021 Apr; 39(4):234.e9-234.e13. PubMed ID: 32958446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
    Thalmann GN; Markwalder R; Walter B; Studer UE
    J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.
    Nonomura N; Ono Y; Nozawa M; Fukui T; Harada Y; Nishimura K; Takaha N; Takahara S; Okuyama A
    Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?
    Territo A; Fontanet S; Meneghetti I; Gallioli A; Sanguedolce F; Rodriguez-Faba Ó; Gaya JM; Palou J; Huguet J; Breda A
    Actas Urol Esp (Engl Ed); 2023 May; 47(4):221-228. PubMed ID: 36379260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin.
    Dinney CP; Greenberg RE; Steinberg GD
    Urol Oncol; 2013 Nov; 31(8):1635-42. PubMed ID: 22575238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ.
    McElree IM; Mott SL; Hougen HY; Packiam VT; O'Donnell MA; Steinberg RL
    Urol Oncol; 2024 Jul; 42(7):221.e9-221.e16. PubMed ID: 38609747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
    Okubo K; Ishitoya S; Maeda H; Suzuki Y; Arai Y
    Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):386-90. PubMed ID: 9125861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B.
    Katz MH; Lee MW; Gupta M
    J Endourol; 2007 Apr; 21(4):374-7; discussion 377. PubMed ID: 17451325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.
    Horiguchi H; Yoneyama T; Hatakeyama S; Tokui N; Sato T; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Narita S; Kawaguchi T; Ohyama C
    Med Oncol; 2018 Feb; 35(4):41. PubMed ID: 29480348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guérin therapy.
    Kojima Y; Tozawa K; Kawai N; Sasaki S; Hayashi Y; Kohri K
    Int J Urol; 2006 Apr; 13(4):340-4. PubMed ID: 16734847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment outcome of intrarenal Bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
    Anan G; Suyama T; Takeuchi N; Nakamura K; Sakamoto S; Nihei N; Ichikawa T
    Hinyokika Kiyo; 2013 May; 59(5):261-4. PubMed ID: 23719131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.
    Miyake H; Eto H; Hara S; Okada H; Kamidono S; Hara I
    Int J Urol; 2002 Dec; 9(12):677-80. PubMed ID: 12492951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
    de Reijke TM; Kurth KH; Sylvester RJ; Hall RR; Brausi M; van de Beek K; Landsoght KE; Carpentier P;
    J Urol; 2005 Feb; 173(2):405-9. PubMed ID: 15643181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ of bladder].
    Uekado Y; Kohjimoto Y; Iba A; Kikkawa K; Shintani Y; Shinka T
    Hinyokika Kiyo; 2006 Jun; 52(6):439-44. PubMed ID: 16848357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical instillation of BCG immunotherapy for biopsy-proven primary upper urinary tract carcinoma in situ: A single institution series and systematic review.
    Fontanet S; Gallioli A; Baboudjian M; Huguet J; Territo A; Gaya JM; Gavrilov P; Izquierdo P; Verri P; Algaba F; Palou J; Breda A
    Urol Oncol; 2023 Jun; 41(6):274-283. PubMed ID: 36526527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.
    Yokogi H; Wada Y; Mizutani M; Igawa M; Ishibe T
    Br J Urol; 1996 May; 77(5):676-9. PubMed ID: 8689109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
    Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter.
    Irie A; Iwamura M; Kadowaki K; Ohkawa A; Uchida T; Baba S
    Urology; 2002 Jan; 59(1):53-7. PubMed ID: 11796281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity.
    Lam JS; Benson MC; O'Donnell MA; Sawczuk A; Gavazzi A; Wechsler MH; Sawczuk IS
    Urol Oncol; 2003; 21(5):354-60. PubMed ID: 14670544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.